Renaissance Technologies's GSK Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 1.04 M shares of GSK plc (GSK) worth $50.78 M, representing 0.08% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 554,600 shares. Largest reduction occurred in Q4 2022, reducing 3.02 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -952,381 | Reduce 47.91% | 1.04 M | $49.04 |
| Q3 2025 | -262,900 | Reduce 11.68% | 1.99 M | $43.16 |
| Q2 2025 | +268,700 | Add 13.56% | 2.25 M | $38.40 |
| Q1 2025 | -773,040 | Reduce 28.06% | 1.98 M | $38.74 |
| Q4 2024 | +419,700 | Add 17.97% | 2.76 M | $33.82 |
| Q3 2024 | -12,500 | Reduce 0.53% | 2.34 M | $40.88 |
| Q2 2024 | +554,600 | Add 30.92% | 2.35 M | $38.50 |
| Q1 2024 | -971,800 | Reduce 35.14% | 1.79 M | $42.87 |
| Q4 2023 | -146,800 | Reduce 5.04% | 2.77 M | $37.06 |
| Q3 2023 | -110,141 | Reduce 3.64% | 2.91 M | $36.25 |
| Q2 2023 | -1.21 M | Reduce 28.55% | 3.02 M | $0.04 |
| Q1 2023 | -2.11 M | Reduce 33.26% | 4.23 M | $0.04 |
| Q4 2022 | -3.02 M | Reduce 32.25% | 6.34 M | $0.04 |
| Q3 2022 | +9.35 M | New Buy | 9.35 M | $29.43 |
Renaissance Technologies's GSK plc Investment FAQs
Renaissance Technologies first purchased GSK plc (GSK) in Q3 2022, acquiring 9,354,057 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held GSK plc (GSK) for 14 quarters since Q3 2022.
Renaissance Technologies's largest addition to GSK plc (GSK) was in Q3 2022, adding 9,354,057 shares worth $275.29 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 1,035,572 shares of GSK plc (GSK), valued at approximately $50.78 M.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 0.08% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in GSK plc (GSK) was 9,354,057 shares, as reported at the end of Q3 2022.